New heart pump could make risky artery procedures safer

NCT ID NCT04477603

Ongoing Disease control Sponsor: Abiomed Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 29 times

Summary

This study tests a small heart pump called Impella ECP in 100 adults having a high-risk angioplasty (a procedure to open blocked heart arteries). The pump helps keep blood flowing during the procedure. The goal is to see if the device is safe and works as intended. Participants are followed to check for device-related problems and whether the pump successfully supports the heart.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Henry Ford Health St. John Hospital

Detroit, Michigan, 48236, United States
Henry Ford Hospital

Detroit, Michigan, 48202, United States
The Christ Hospital

Cincinnati, Ohio, 45219, United States
The Valley Hospital

Paramus, New Jersey, 07652, United States
Tufts Medical Center

Boston, Massachusetts, 02111, United States

Conditions

Explore the condition pages connected to this study.

HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION